Editas, Allergan open first trial of in vivo CRISPR therapy
One of the four sites of the trial, in a rare form of inherited blindness, is currently listed as open for enrollment, and the companies plan to dose the first patient soon.
Editas to deploy CRISPR therapy in humans by 2017
Looks like CRISPR is headed to the clinic: Editas Medicine just announced that it'll bring this gene editing technology to human trials by 2017.
Navigating The Right Steps For Your Healthcare Startup
This webinar will explore how a banking platform approach could be the resource for your company.